NEW YORK (
) hit a new 52-week low Monday as it is currently trading at $3.74, below its previous 52-week low of $3.75 with 586,455 shares traded as of 2:54 p.m. ET. Average volume has been 1.2 million shares over the past 30 days.
Affymetrix has a market cap of $272 million and is part of the
industry. Shares are down 24.5% year to date as of the close of trading on Friday.
Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates Affymetrix as a
. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and generally disappointing historical performance in the stock itself. You can view the full
or get investment ideas from our